Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis-Reference-Cited by-同舟云学术

Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis

Published:2021-01 Issue:1 Volume:27 Page:70.e1-70.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Tachibana Takayoshi,Kanda Junya,Ishizaki Takuma,Najima Yuho,Tanaka Masatsugu,Doki Noriko,Fujiwara Shin-ichiro,Kimura Shun-ichi,Onizuka Makoto,Takahashi Satoshi,Saito Takeshi,Mori Takehiko,Fujisawa Shin,Sakaida Emiko,Miyazaki Takuya,Aotsuka Nobuyuki,Gotoh Moritaka,Watanabe Reiko,Shono Katsuhiro,Usuki Kensuke,Tsukada Nobuhiro,Kanamori Heiwa,Kanda Yoshinobu,Okamoto Shinichiro

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference31 articles.

1. Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation;Wong;Biol Blood Marrow Transplant,2005

2. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up;Oyekunle;Bone Marrow Transplant,2006

3. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure;Duval;J Clin Oncol,2010

4. Prognostic factors for outcomes of pediatric patients with refractory or relapsed acute leukemia undergoing allogeneic progenitor cell transplantation;Watanabe;Biol Blood Marrow Transplant,2011

5. Factors affecting outcome of allogeneic stem cell transplantation as salvage in patients with acute myeloid leukemia primary refractory to intensive induction therapy;Medeot;Am J Hematol,2014